SRY (sex determining region Y)-box2 (Sox2)/poly ADP-ribose polymerase 1 (Parp1) complexes regulate pluripotency

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 10, 2012, Pages 3772-3777

  Lai, Yi Shin ^a,b   Chang, Chia Wei ^a,b   Pawlik, Kevin M ^a,b   Zhou, Dewang ^a,b   Renfrow, Matthew B ^a,b   Townes, Tim M ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Gene targeting; Regulatory pathway; Tagged mice

Indexed keywords

FIBROBLAST GROWTH FACTOR; HEMAGGLUTININ; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ARTICLE; CELLULAR PARAMETERS; CHEMICAL LABELING; CONTROLLED STUDY; EMBRYONIC STEM CELL; HOMOLOGOUS RECOMBINATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; PLURIPOTENCY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ADENOSINE DIPHOSPHATE; ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; GENE TARGETING; MASS SPECTROMETRY; MICE; MODELS, GENETIC; PLURIPOTENT STEM CELLS; POLY(ADP-RIBOSE) POLYMERASES; RECOMBINATION, GENETIC; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS;

MUS;

EID: 84863229248     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1108595109     Document Type: Article

References (58)

1. Smith AG, et al. (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336:688-690. (Pubitemid 19007952)
2. Ying QL, Nichols J, Chambers I, Smith A (2003) BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115:281-292. (Pubitemid 37487702)
3. Nichols J, Silva J, Roode M, Smith A (2009) Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development 136:3215-3222.
4. Kunath T, et al. (2007) FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134:2895-2902. (Pubitemid 47386902)
5. Nichols J, et al. (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391. (Pubitemid 28507326)
6. Catena R, et al. (2004) Conserved POU binding DNA sites in the Sox2 upstream enhancer regulate gene expression in embryonic and neural stem cells. J Biol Chem 279:41846-41857. (Pubitemid 39313633)
7. Chambers I, et al. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643-655. (Pubitemid 36694189)
8. Yuan H, Corbi N, Basilico C, Dailey L (1995) Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev 9:2635-2645.
9. Rodda DJ, et al. (2005) Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 280:24731-24737. (Pubitemid 40934562)
10. Kuroda T, et al. (2005) Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 25:2475-2485. (Pubitemid 40354640)
11. Chew JL, et al. (2005) Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 25:6031-6046.
12. Orkin SH, et al. (2008) The transcriptional network controlling pluripotency in ES cells. Cold Spring Harbor Symp Quant Biol 73:195-202.
13. Chen X, et al. (2008) Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133:1106-1117. (Pubitemid 351787745)
14. Chambers I, Tomlinson SR (2009) The transcriptional foundation of pluripotency. Development 136:2311-2322.
15. Ouyang Z, Zhou Q, Wong WH (2009) ChIP-Seq of transcription factors predicts absolute and differential gene expression in embryonic stem cells. Proc Natl Acad Sci USA 106:21521-21526.
16. Rodriguez RT, et al. (2007) Manipulation of OCT4 levels in human embryonic stem cells results in induction of differential cell types. Exp Biol Med (Maywood) 232:1368-1380. (Pubitemid 350014427)
17. Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376. (Pubitemid 30187435)
18. Boer B, et al. (2007) Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2 : Oct-3/4 target genes. Nucleic Acids Res 35:1773-1786. (Pubitemid 47061649)
19. Kopp JL, Ormsbee BD, Desler M, Rizzino A (2008) Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 26:903-911.
20. Bernadt CT, Nowling T, Rizzino A (2004) Transcription factor Sox-2 inhibits co-activator stimulated transcription. Mol Reprod Dev 69:260-267. (Pubitemid 39315007)
21. Chickarmane V, et al. (2006) Transcriptional dynamics of the embryonic stem cell switch. PLoS Comput Biol 2:e123.
22. Heng JC, Ng HH (2010) Transcriptional regulation in embryonic stem cells. Adv Exp Med Biol 695:76-91.
23. Pan G, et al. (2006) A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J 20:1730-1732.
24. Gao F, Kwon SW, Zhao Y, Jin Y (2009) PARP1 poly(ADP-ribosyl)ates Sox2 to control Sox2 protein levels and FGF4 expression during embryonic stem cell differentiation. J Biol Chem 284:22263-22273.
25. Ame JC, Spenlehauer C, de Murcia G (2004) The PARP superfamily. BioEssays 26:882-893. (Pubitemid 39128102)
26. Krishnakumar R, Kraus WL (2010) The PARP side of the nucleus: Molecular actions, physiological outcomes, and clinical targets. Mol Cell 39:8-24.
27. Alvarez-Gonzalez R, Jacobson MK (1987) Characterization of polymers of adenosine diphosphate ribose generated in vitro and in vivo. Biochemistry 26:3218-3224. (Pubitemid 17087859)
28. Althaus FR, Richter C (1987) ADP-ribosylation of proteins. Enzymology and biological significance. Mol Biol Biochem Biophys 37:1-237.
29. Dantzer F, et al. (1999) Poly(ADP-ribose) polymerase activity is not affected in ataxia telangiectasia cells and knockout mice. Carcinogenesis 20:177-180. (Pubitemid 29033862)
30. Satoh MS, Lindahl T (1992) Role of poly(ADP-ribose) formation in DNA repair. Nature 356:356-358.
31. Caiafa P, Guastafierro T, Zampieri M (2009) Epigenetics: Poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns. FASEB J 23:672-678.
32. Wang Y, Dawson VL, Dawson TM (2009) Poly(ADP-ribose) signals tomitochondrial AIF: A key event in parthanatos. Exp Neurol 218:193-202.
33. Ame JC, et al. (1999) PARP-2, A novel mammalian DNA damage-dependent poly(ADPribose) polymerase. J Biol Chem 274:17860-17868.
34. Shieh WM, et al. (1998) Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers. J Biol Chem 273:30069-30072. (Pubitemid 28545464)
35. Wang ZQ, et al. (1995) Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 9:509-520.
36. Menissier de Murcia J, et al. (2003) Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J 22:2255-2263. (Pubitemid 36565548)
37. Schreiber V, et al. (2002) Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem 277:23028-23036. (Pubitemid 34967289)
38. Ogino H, et al. (2007) Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cells. BMC Genomics 8:41.
39. Krishnakumar R, et al. (2008) Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 319:819-821. (Pubitemid 351225873)
40. Tulin A, Stewart D, Spradling AC (2002) The Drosophila heterochromatic gene encoding poly(ADP-ribose) polymerase (PARP) is required to modulate chromatin structure during development. Genes Dev 16:2108-2119.
41. +-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 119:803-814.
42. + into a nuclear signal. Genes Dev 19:1951-1967.
43. D'Amours D, Desnoyers S, D'Silva I, Poirier GG (1999) Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342:249-268. (Pubitemid 29425344)
44. Leppard JB, Dong Z, Mackey ZB, Tomkinson AE (2003) Physical and functional interaction between DNA ligase IIIalpha and poly(ADP-Ribose) polymerase 1 in DNA singlestrand break repair. Mol Cell Biol 23:5919-5927. (Pubitemid 36951352)
45. Heale JT, et al. (2006) Condensin I interacts with the PARP-1-XRCC1 complex and functions in DNA single-strand break repair. Mol Cell 21:837-848. (Pubitemid 43376133)
46. Ju BG, et al. (2004) Activating the PARP-1 sensor component of the groucho/TLE1 corepressor complex mediates a CaMKinase IIdelta-dependent neurogenic gene activation pathway. Cell 119:815-829.
47. Lu J, et al. (2009) All-trans retinoic acid promotes neural lineage entry by pluripotent embryonic stem cells via multiple pathways. BMC Cell Biol 10:57.
48. Stavridis MP, Collins BJ, Storey KG (2010) Retinoic acid orchestrates fibroblast growth factor signalling to drive embryonic stem cell differentiation. Development 137:881-890.
49. Kauppinen TM, et al. (2006) Direct phosphorylation and regulation of poly(ADPribose) polymerase-1 by extracellular signal-regulated kinases 1/2. Proc Natl Acad Sci USA 103:7136-7141.
50. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676. (Pubitemid 44233629)
51. Hanna J, et al. (2009) Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462:595-601.
52. Yamaguchi S, Hirano K, Nagata S, Tada T (2011) Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate. Stem Cell Res 6:177-186.
53. Papapetrou EP, et al. (2009) Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci USA 106:12759-12764.
54. Niwa H, Ogawa K, Shimosato D, Adachi K (2009) A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460:118-122.
55. Jeong CH, et al. (2010) Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cells. Stem Cells 28:2141-2150.
56. Zhou D, et al. (2004) Rapid tagging of endogenous mouse genes by recombineering and ES cell complementation of tetraploid blastocysts. Nucleic Acids Res 32:e128.
57. Joo HY, et al. (2011) Regulation of histone H2A and H2B deubiquitination and Xenopus development by USP12 and USP46. J Biol Chem 286:7190-7201.
58. Eliuk SM, et al. (2007) Active site modifications of the brain isoform of creatine kinase by 4-hydroxy-2-nonenal correlate with reduced enzyme activity: Mapping of modified sites by Fourier transform-ion cyclotron resonance mass spectrometry. Chem Res Toxicol 20:1260-1268. (Pubitemid 47548294)